ZVRA
Zevra Therapeutics Inc.
NASDAQ: ZVRA · HEALTHCARE · BIOTECHNOLOGY
$9.67
-2.32% today
Updated 2026-04-29
Market cap
$585.24M
P/E ratio
7.33
P/S ratio
5.50x
EPS (TTM)
$1.35
Dividend yield
—
52W range
$7 – $13
Volume
1.1M
Zevra Therapeutics Inc. (ZVRA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+54.7%
Last 4 quarters
Revenue YoY growth
+183.4%
Most recent quarter
EPS YoY growth
+127.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-7.5%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-7.9%
2026-03-11
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-11 | $0.19 | +280.0% | $11.06 | $10.19 | -7.9% |
| 2025-11-05 | $-0.01 | +66.7% | $9.79 | $9.09 | -7.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.05 | $0.19 | +280.0% | $34.13M | +183.4% |
| 2025-09-30 | $-0.03 | $-0.01 | +66.7% | $26.06M | +605.4% |
| 2025-06-30 | $2.19 | $-0.06 | -102.7% | $25.88M | +481.7% |
| 2025-03-31 | $-0.18 | $-0.06 | +66.9% | $20.40M | +495.6% |
| 2024-12-31 | $-0.40 | $-0.69 | -73.1% | $12.04M | — |
| 2024-09-30 | $-0.42 | $-0.69 | -64.3% | $3.69M | +27.6% |
| 2024-06-30 | $-0.43 | $-0.48 | -11.6% | $4.45M | -47.5% |
| 2024-03-31 | $-0.48 | $-0.40 | +16.7% | $3.42M | +7.8% |
| 2023-12-31 | $-0.27 | $-0.40 | -48.1% | — | — |
| 2023-09-30 | $-0.30 | $-0.40 | -33.3% | $2.90M | — |
| 2023-06-30 | $-0.34 | $-0.15 | +55.9% | $8.47M | — |
| 2023-03-31 | $-0.23 | $-0.34 | -47.8% | $3.18M | — |
Frequently asked questions
Has Zevra Therapeutics Inc. beaten earnings estimates?
Zevra Therapeutics Inc. has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +54.7% over the last 3 quarters.
How does ZVRA stock react to earnings?
ZVRA stock has moved an average of -7.5% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Zevra Therapeutics Inc.'s revenue growth rate?
Zevra Therapeutics Inc. reported year-over-year revenue growth of +183.4% in its most recent quarter, with EPS growing +127.5% year-over-year.